1. Field of the Invention
The present invention relates to a device for penetrating tissue and delivering bioactive agents thereto or extracting biological materials therefrom.
More particularly, the present invention relates to tissue penetration devices for delivering biologically active agents into tissue sites or extracting biological materials from the tissue sites where the device includes specially designed needles for penetrating a tissue site either rotationally or non-rotationally and specially designed delivery or extraction devices for controlled delivery of materials into tissue sites or extraction of materials from tissue sites.
2. Description of the Related Art
Accurate and effective tissue penetration and accurate and effective delivery of bioactive agents or extraction of biological fluids or material is regime of needle incorporating devices. Several patents have dealt with such needle incorporating devices including the following U.S. Pat. Nos. 1,523,068, 2,773,500, 2,773,501, 3,788,320, 3,811,442, 3,893,445, 4,666,438, 4,787,893, 4,969,870, 5,176,643, 5,271,744, and 5,312,364.
Although these patents generally relate to syringe and needle assemblies for the delivery of material into or extraction of material out of a tissue site, there is still a need in the art for new, efficient and controlled delivery and extraction devices incorporating new, efficient needles which reduce penetration time and improve penetration efficiency into sensitive tissue sites.
The present invention provides a device for delivering materials into or extracting materials from tissue sites. The device includes a fluid reservoir, a tissue penetrator or needle detachably engaging a first end of the reservoir and a plunger associated with the reservoir at its second end and designed to slidingly engage an interior surface of the reservoir. The device further includes at least one solenoid having a shaft detachably engaging a top of the plunger for moving the plunger within the reservoir, a power supply and associated circuitry for supply electrical power to the solenoid and at least one switch for controlling the solenoid. Preferably, the entire assembly is contained within a housing including a biased retractable tip protector (preferably, disposable) at its distal end having a penetrator. Additional solenoids can be used to control needle penetration speed and depth or to allow simultaneous or sequential infusion or removal of materials into or out of a tissue site.
The present invention provides a device for delivering materials into or extracting materials out of tissue sites. The device includes a reservoir/solenoid assembly as described above and additionally, a motor assembly for rotating the solenoid/reservoir assembly and at least one control switch with associated circuitry for activating the motor either in cooperation with the solenoid or independent from the switches and circuitry associated with the solenoid. Again, additional solenoids can be used to control needle penetration speed and depth by pushing against the motor assembly coordinated with needle rotation or to allow simultaneous or sequential infusion or removal of materials into or out of a tissue site.
The present invention also provides a tissue penetrator or needle including a hollow tubular member having a first end, a second end having a tissue penetrating tip associated therewith and at least one perforation therein located between a mid point of the hollow member and the tip end of the hollow member. The tissue penetrating tip includes two opposed cutting surfaces, each having a cutting edge, two opposed non-cutting surfaces and an opening associated with the tip at or near the apex. The hollow member can also include an enlarged region or seal for creating a seal between the penetrated tissue site and the penetrator.
This invention also provides a method for delivering material to a tissue site including positioning a tissue penetration device as described above in proximity to a tissue site to be penetrated, penetrating the tissue site with the penetrator, and activating the solenoid to deliver material into the tissue site from the reservoir of the penetration device or transfer material from the reservoir to the tissue site.
The present invention also provides a method for extracting material from a tissue site including positioning a tissue penetration device as described above in proximity to a tissue site to be penetrated, penetrating the tissue site with the penetrator, and activating the solenoid to extract material from the tissue site or transfer material from the tissue site to the reservoir.
This invention also provides a method for delivering material to a tissue site including positioning a tissue penetration device as described above in proximity to a tissue site to be penetrated, rotationally penetrating the tissue site with the penetrator, and activating the solenoid to transfer material from the reservoir to the tissue site.
The present invention also provides a method for extracting material from a tissue site including positioning a tissue penetration device as described above in proximity to a tissue site to be penetrated, rotationally penetrating the tissue site with the penetrator, and activating the solenoid to transfer material from the tissue site to the reservoir.
The invention can be better understood with reference to the following detailed description together with the appended illustrative drawings in which like elements are numbered the same:
The inventors have found that a device can be constructed for the efficient and controlled penetration of tissue sites and the subsequent controlled introduction of material into or extraction of material from a tissue site, i.e., transferring material into or out of a tissue site. Such a device, although having broad application in all tissue penetration applications, has special utility in hard tissue penetration applications such as bone, cartilage, tendon, ligaments or the like. The devices can be used on any animal, but is preferably designed for use with mammals and especially humans.
The device also allows for protection of health care providers from accidental needle pricks, while providing ease of operation and solenoid controlled introduction of materials into or extraction of materials from tissues sites. The device also incorporates a specially designed needle attached to a high speed motor for fast and easy penetration of hard tissues such as bone, cartilage, tendon, ligaments or the like The device can also be equipped with torque sensors associated with the motor so that the motor will automatically stop needle rotation when a given change in torque occurs such as when the needle transition from bone to soft tissue. The torque sensor and associated circuitry can also activate the solenoid either immediately after shutting off the motor or after a delay so that manual adjustments can be made prior to solenoid activation. Of course, motor power and solenoid power can be manually controlled either cooperatively or independently depending on the circuitry associated with the device or upon switch selections associated with the circuitry associated with the device.
The present invention discloses a new device and methodology for use in accurate tissue penetration and delivery of materials (bioactive material such as medications, fillers, tags or tracking agents, implants, or the like) into a tissue site or extraction of materials (bodily fluids, biopsies, tissues samples, bone marrow or the like) from a tissue site.
For example in marrow aspiration, the device would be placed on (in contact with) the bone cortex and the tissue penetrator member or needle, which resides at the device's distal end, would be rotated by the motor until it penetrates the cortical bone to a pre-determined depth. The penetration depth can either be adjusted by an adjustable depth stop or by having the motor sensor automatically shut the motor off when a turning torque for the needle indicates full penetration of the bone cortex (sudden drop in turning torque). At that instance, the solenoid (or similar electrically activated retraction device) in a “pull” configuration is either manually or automatically activated or powered up and bone marrow is aspirated into the needle's hollow shaft through orifices or perforations in the shaft and/or through an opening in the needle tip. The material travels through the needle and is accumulated in the device's storage reservoir.
In this example, the penetrator rotates without linear translation or extension with penetration pressure being supplied by the user. Once appropriate penetration (and thus tip positioning) is achieved, power to the motor is manually or automatically discontinued and power to the solenoid is initiated either manually or automatically. The solenoid then retracts and aspirates (removes) material from the tissue site or pushes out and delivers materials to the tissue site. The device can be easily fabricated at a low cost.
Applications
The devices of the present invention can be used for a number of medical applications, including, without limitation, the following:
1. Intra-joint Fluid Aspiration:
The penetrator or needle of the device is driven into a tissue site without rotation by a solenoid in a push condition (sometime referred to as a “push” solenoid). Once the needle tip is at the desired location, a second solenoid in a pull condition (sometimes referred to as a “pull” solenoid) is used to aspirate or remove material such as fluid from the tissue site. In this embodiment, the device does not need to have a motor. This embodiment and use of the device allows for extraction of synovial fluids, e.g., to quantify the presence of metallo-proteases or other markers of osteoarthritis, of blood or fluids to alleviate joint pressure, blood to perform culture studies or the like.
2. Intra-joint Delivery Device:
Similarly, a “push” solenoid lets the needle penetrate the joint in a linear fashion. Once the desired penetration is accomplished, a mechanical stop acts as an electrical switch for a second “push” solenoid, which applies positive pressure on the plunger of the syringe (reservoir) until all of its contents (such as bioactive agents) are released (delivered) into the joint. In this embodiment, the device also does not need to have a motor. This embodiment and use of the device allows for delivery of anti-inflammatory drugs and/or painkillers (e.g., lidocaine) or of articular cartilage surface coating fluids (e.g., hyaluronic acid, anti-arthritic agents) or the like.
3. Intraosseous Delivery of Drugs or Bioactive Agents:
An example is the delivery of drugs, pharmaceuticals, growth factors, etc. inside the marrow cavity of a bone. For example, if a drug needs to be delivered in the marrow cavity of the antero-medial diaphyseal portion of the tibia, or in a tibial metaphysical portion, the device is positioned perpendicularly on the skin over the region of the bone to be penetrated. As the user applies some pressure on the device, the penetrator (preferably a needle of the paddle-tipped hollow needle design described herein) protrudes from the housing through the septum associated with the tip protector, cuts through the skin and rests on the periosteum. The user switches the motor on and the needle penetrates through the cortex, until a mechanical stop is reached (say after a 15 mm penetration). The mechanical stop then acts as an electrical sensor and/or switch, which selectively turns the motor off and powers up or activates the solenoid. The solenoid then pushes out and applies a compressive force on the plunger of the syringe. The drug is pushed out through the orifices placed on the lateral aspects of the needle and/or through the opening in the center of the needle tip. Of course, the motor activation can be controlled by sensors associated with the device. One sensor could determine when bone contact has occurred (pressure sensor), while other sensors could determine when a change in torque has occurred which would indicate a transition from a bone type medium to a soft tissue medium or a less bone-like medium depending on the nature of the torque sensors.
The devices of the present invention do not depend on developing large momentum or subsequent impact to achieve penetration as do many prior art devices. The devices of the present invention penetrate by developing large strains locally in bone close to the interface with the cutting edges of the penetrator. As a result, this method completely eliminates the possibility of fracturing bone as may be the case in momentum or impact tissue penetration devices. The devices of the present invention also allows for proper controlled delivery of materials into a tissue site reducing if not eliminating delivery until a desired penetration is achieved.
Fluid delivery, moreover, does not depend on inertial forces developed due to impact. Because it is difficult to control the inertial force in the syringe fluid in momentum-based delivery systems, it is difficult to consistently deliver the same amount of fluid every time to a given tissue site. In the devices of the present invention, fluid delivery is much more controlled making uniform and consistent administration of materials to a tissue site routine. This uniformity and consistency is accomplished through the use of solenoid (or a similar) delivery systems, which delivers or extracts the same amount of material every time because the solenoid uses the same amount of electrical energy and force profile during administration as opposed to user administration.
4. Intracranial Pressure Release:
In traumatic head injuries, swelling due to fluid adjacent to the brain may develop which can lead to death or brain damage. Such fluid build up can be relieved using the devices of the present invention by penetrating the cranium in the vicinity of the site of injury. Once penetration of the cranium is achieved by drilling through the cranium with the penetrator or needle, the motor automatically stops (this is accomplished by shutting down the power to the motor when a reduction of motor-torque is detected either manually or automatically). After drilling, the needle can be further inserted into the soft tissue inside the cranium using user-applied force until a desired penetration depth is achieved. A “pull” solenoid can then pull the plunger of the syringe thus creating negative pressure that will aspirate the excess fluid into the reservoir.
5. Intracranial Delivery of Bioactive Agents:
The devices of this invention can also be used to deliver medication such as cancer drugs to brain tumors. As in application 4, the device penetrates the cranium and stops immediately when the needle contacts intracranial soft tissue (torque change on the needle). The user continues to apply a small compressive force and thus the needle travels into the soft tissue. When a desired penetration is achieved, a mechanical stop brings the needle to a stop and also closes the solenoid circuit. A “push” solenoid pushes the plunger of the syringe until all fluid contents of the syringe are delivered inside the tumor. This process can be adjusted to proceed at any given rate from very fast delivery to very slow delivery. Although the delivery of anti-cancer agents may require fast delivery, the administration of medications to ameliorate the adverse effects of brain injuries such as calpain inhibitors or growth promoters may require slow continuous administration.
6. Marrow Extraction:
The devices of the present invention can also be used to access the marrow cavity of a given bone. Using a “pull” solenoid, we can create a vacuum in the syringe which will aspirate a desired amount of marrow fluid. Examples of extraction are: bone marrow is aspirated for transplantation for cancer patients or marrow is aspirated to obtain mesenchymal stem cells or other cells to be used in cell-based transplantation therapies.
7. Spinal Fluid Extraction:
A similar technique as described in 6 above can be used to aspirate spinal fluid. A double solenoid can be used, where one pushes the syringe into a proper position and another solenoid pulls and thus aspirates the fluid out.
8. Compartment Syndrome:
Similarly, this system can be used to relieve pressure developed in a compartment syndrome.
The devices of the present invention should preferably have a disposable distal end because the distal surface comes in contact with skin and may become contaminated with bodily fluids (e.g., blood) that may potentially exude through the penetration orifice and carry viral or bacterial infections. The device also is equipped with a septum protected needle to aid in preventing needle pricks because the needle before and after use is protected within the retractable and preferably disposable tip protector. The device can include custom made battery packs and chargers preferably waterproof, made of medical grade materials, and preferably include sensor that will monitor and indicate battery charge. The devices can have different heads (distal ends) which allow or permit different needle penetration depth and/or have sensors to measure needle to tissue pressure. Penetration depth control can be achieved by having mechanical stops on the retractable tip. Needles of various size and gages can be used as well. The device, moreover, can be used to implant small microdevices into tissue sites and even for screwing threaded bone pins into bone site to repair fractures.
Paddle-Tipped Hollow Needle
The inventors have also found that a new needle tip design can greatly facilitate penetration of hard tissue such as bone with reduced ancillary bond injury or fracturing. The needle is of a paddle-tipped hollow design. The needle includes two opposing cutting surfaces with cutting edges off the perpendicular and two opposed non-cutting surfaces. The needle tip is generally in the form of a quadrilateral (rectangular or parallelogram) with cutting surfaces associated with its short sides and non-cutting surfaces associated its long sides. The tip has a first interior angle that is generally less than 90° (rectangular) and greater than about 0° (linear) and a second interior angle which is 180° minus the first angle. Preferably, the first angle is between about 80° and about 10°, more particularly the first angle (which is an acute angle) is between about 80° and about 50°, and especially the first angle is between about 80° and about 60°, with 70° being particularly preferred. As shown in the diagrams (
The needle design has the following features: (1) the needle design eliminates friction between needle surface and bone, thus, it decreases time of penetration and thermal damage to the bone; (2) the needle has two cutting edges on the two thin sides of flat triangular profiled surfaces; (3) on the proximal end there is a taper to enlarge the diameter of the needle shaft to match the hole size created by the paddled bit in order to seal the fluid and prevent leaking on injection (
Referring now to
The device 10 further includes a retractable cap 14 which slidingly engages an interior surface 16 of housing 12 at its distal end 18. The cap 14 is biased by a bias member 20 which has a first end 22 associated with the cap 14 and a second end 24 associated with a contact switch 26 for initiating fluid ejection. The cap 14 also includes a user adjustable depth stop 28 and a needle penetrable membrane 30 associated with its bottom surface 32 which is placed in contact with a patient during use.
The device 10 further includes a needle 34 positioned with in the device 10 so that its tip 36 is poised to penetrate the membrane 30. The needle 34 is detachably or fixedly attached to a needle holder 38 at its opposite end 40. The holder 38 is associated with a fluid reservoir 42 and forms the reservoir's needle end 44. The reservoir 42 has a plunger 46 which slidingly engages an interior surface 48 of the reservoir 42. The plunger 46 acts to either force fluid out of the reservoir or suck fluid into the reservoir depending on whether the device is being used to delivery material to a tissue site or withdraw material from a tissue site.
The device 10 further includes a solenoid 50, an electrical contact bushing 52, a bearing 54, a solenoid/needle coupler 56 and a solenoid shaft 58. The shaft 58 has a distal end 60 is either fixedly or detactably attached to or associated with a top of the plunger 46 so that the plunger 46 can be moved vertically within the reservoir 42. If the shaft 58 is fully extended prior to use, then the solenoid 50 will retract the shaft 58 and the device 10 will act to remove material from the tissue site. If the shaft 58 is fully retracted, then the solenoid 50 will extend the shaft 58 and the device 10 will act to inject material into the tissue site. The coupler 56 has a lip 62 that contacts a top edge 64 of the reservoir 42. The lip 62 allows the reservoir 42 and associated needle assembly to be pushed downward so that needle penetration can be controlled by the solenoid 50 instead of being controlled manually. Of course, the depth and rate of penetration as well as the rate to removal can be manually controlled or controlled by a second solenoid (not shown).
The device 10 further includes a high speed DC motor 66 and a motor/solenoid coupler 68. The motor allows the entire solenoid/reservoir/needle assembly to be rotated so that the needle can drill into hard tissues such as bone. The bearing 54 is positioned within a groove 70 in the housing 12 so that the solenoid/reservoir/needle assembly can be rotated relative to the housing 12.
The device 10 further includes an on/off switch 72, a battery 74, battery charging ports 76 and a relay circuit 78. A preferred electrical communication schematic for the operation of the device 10 using the switch 72, battery 74 and relay circuit 78 is shown in
Referring to
Referring to
Referring now to
The device 110 also includes a motor assembly 134 which includes the motor and a female threaded connection 136 associated with its distal end 138 and designed to threadingly engage the male connector 124 and a male threaded connection 140 associated with its proximal end 142 and a rotatory shaft 141. The device finally includes a battery assembly 144 having a female threaded connection 146 associated with its distal end 148 and designed to threadingly engage the male connector 140. Of course, the battery assembly 144 includes the battery, the switch and the relay circuit and can be vertically disposed or positioned or horizontally disposed or positioned relative to the other assemblies to produce the assembled devices depicted in
Although the assemblies shown in
Referring now to
As shown
Referring now to
The tapered V-shaped side view of the tips 206 of the needles of
Although the tip is shown as a parallelogram shape having two opposed cutting surfaces and edges, the present invention also contemplates other polygonally shaped tips including rectangular with two cutting surfaces, pentagons with two or three cutting surfaces, hexagons with three cutting surfaces, etc. where the sides of the polygons are not equal so that the cutting edges are associated with smaller sides of the polygonal shape and can have sharp well defined cutting edges.
The following examples are included for the sake of completeness of disclosure and to illustrate the methods of making the compositions and composites of the present invention as well as to present certain characteristics of the compositions, but in no way are these examples included for the sake of limiting the scope or teaching of this disclosure.
In preliminary experiments using a prototype device of the present invention using the new needle configuration, the inventors were able to achieve complete penetration of cortical bone in 100% of the cases in 1.3 seconds while the whole process currently takes approximately 2 to about 2.5 seconds (injection or removal of material). The inventors also analyzed time of full penetration plotted against cortical thickness as shown in
All United States patents, all foreign patents and all articles cited therein are incorporated herein by reference as if each was incorporated by reference at the time of introduction. Although the invention has been disclosed with reference to its preferred embodiments, from reading this description those of skill in the art may appreciate changes and modification that may be made which do not depart from the scope and spirit of the invention as described above and claimed hereafter.
This application is a continuation of U.S. patent application Ser. No. 09/757,122 filed Jan. 9, 2001, now U.S. Pat. No. 6,527,778, issued Mar. 4, 2003, which is a divisional of U.S. patent application Ser. No. 09/033,105 filed Mar. 2, 1998, now U.S. Pat. No. 6,183,442, issued Feb. 6, 2001.
Number | Name | Date | Kind |
---|---|---|---|
2317648 | Siqveland | Apr 1943 | A |
2679843 | May | Jun 1954 | A |
2701566 | Krug | Feb 1955 | A |
2904045 | Owings | Sep 1959 | A |
4660570 | Dombrowski | Apr 1987 | A |
4695274 | Fox | Sep 1987 | A |
4787893 | Villette | Nov 1988 | A |
4919146 | Rhinehart et al. | Apr 1990 | A |
4950246 | Muller | Aug 1990 | A |
4969870 | Kramer et al. | Nov 1990 | A |
5122114 | Miller et al. | Jun 1992 | A |
5139500 | Schwartz | Aug 1992 | A |
5178628 | Otsuka et al. | Jan 1993 | A |
5195985 | Hall | Mar 1993 | A |
5263974 | Matsutani et al. | Nov 1993 | A |
5312364 | Jacobs | May 1994 | A |
5332398 | Miller et al. | Jul 1994 | A |
5431655 | Melker et al. | Jul 1995 | A |
5476480 | Matsutani et al. | Dec 1995 | A |
5478328 | Silverman et al. | Dec 1995 | A |
5690618 | Smith et al. | Nov 1997 | A |
5762639 | Gibbs | Jun 1998 | A |
5779708 | Wu | Jul 1998 | A |
5810826 | Akerfeldt et al. | Sep 1998 | A |
5848996 | Eldor | Dec 1998 | A |
5927976 | Wu | Jul 1999 | A |
RE36447 | Byrne et al. | Dec 1999 | E |
6096042 | Herbert | Aug 2000 | A |
6135769 | Kwan | Oct 2000 | A |
6183442 | Athanasiou et al. | Feb 2001 | B1 |
6210376 | Grayson | Apr 2001 | B1 |
6213977 | Hjertman et al. | Apr 2001 | B1 |
6217561 | Gibbs | Apr 2001 | B1 |
6228088 | Miller et al. | May 2001 | B1 |
6247928 | Meller et al. | Jun 2001 | B1 |
6273715 | Meller et al. | Aug 2001 | B1 |
6283970 | Lubinus | Sep 2001 | B1 |
6287114 | Meller et al. | Sep 2001 | B1 |
6315737 | Skinner | Nov 2001 | B1 |
6547755 | Lippe et al. | Apr 2003 | B1 |
20010012926 | Gross et al. | Aug 2001 | A1 |
20010014439 | Meller et al. | Aug 2001 | A1 |
20010053888 | Athanasiou et al. | Dec 2001 | A1 |
20020042581 | Cervi | Apr 2002 | A1 |
Number | Date | Country |
---|---|---|
2581548 | May 1985 | FR |
1452790 | Oct 1976 | GB |
WO 7900221 | May 1979 | JP |
WO 9625965 | Feb 1995 | WO |
Number | Date | Country | |
---|---|---|---|
20030114858 A1 | Jun 2003 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09033105 | Mar 1998 | US |
Child | 09757122 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 09757122 | Jan 2001 | US |
Child | 10266452 | US |